Identification and characterization of a photolytic degradation product of telmisartan using LC-MS/TOF, LC-MSn, LC-NMR and on-line H/D exchange mass studies

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 3, 2010, Pages 755-761

  Shah, Ravi P ^a   Singh, Saranjit ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Degradation product; Hydrogen deuterium exchange study; LC MS; LC NMR; Telmisartan

Indexed keywords

TELMISARTAN;

ARTICLE; DRUG ANALYSIS; DRUG DEGRADATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; TEMPERATURE STRESS; TIME OF FLIGHT MASS SPECTROMETRY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEUTERIUM; DRUG STABILITY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PHOTOLYSIS;

EID: 77954864259     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.05.005     Document Type: Article

References (12)

1. Available at: (accessed on 10 January 2010). http://www.medicinenet.com/telmisartan/article.htm.
2. Brunetto M.R., Contreras Y., Clavijo S., Torres D., Delgado Y., Ovalles F., Ayala C., Gallignani M., Estela J.M., Martin V.C. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection. J. Pharm. Biomed. Anal. 2009, 50:194-199.
3. Chen B., Liang Y., Wang Y., Deng F., Zhou P., Guo F., Huang L. Development and validation of liquid chromatography-mass spectrometry method for the determination of telmisartan in human plasma. Anal. Chim. Acta 2005, 540:367-373.
4. Kristoffersen L., Øiestad E.L., Opdal M.S., Krogh M., Lundanes E., Christophersen A.S. Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhytmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry: method development and robustness testing by experimental design. J. Chromatogr. B 2007, 850:147-160.
5. Zhu X., Sun J., Hao H., Wang G., Hu X., Lv H., Gu S., Wu X., Xu J. Simultaneous determination of multiple angiotensin type 1 receptor antagonists and its application to high-throughput pharmacokinetic study: cassette dosing versus cassette analysis. Int. J. Mass Spectrom. 2008, 272:127-136.
6. ICH Stability testing of new drug substances and products Q1A(R2). International Conference on Harmonisation 2003.
7. ICH Stability testing: photostability testing of new drug substances and products Q1B. International Conference on Harmonisation 1996.
8. Singh S., Bakshi M. Guidance on the conduct of stress tests to determine inherent stability of drugs. Pharm. Tech. On-line 2000, 1-14.
9. Shah R.P., Kumar V., Singh S. Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products. Rapid Commun. Mass Spectrom. 2008, 22:613-622.
10. Mehta S., Shah R.P., Singh S. Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: application to valsartan, a model drug. Drug Test Anal. 2010, 2:82-90.
11. n, on-line H/D exchange and LC-NMR. J. Pharm. Biomed. Anal. 2010, 51:1037-1046.
12. Moore D.E. The Photostability of Drugs and Drug Formulations 2004, 10-37. Taylor and Francis, London. 2nd ed. H.H. Tønnesen (Ed.).